FABP5 and neoplasm: Both silencing of FASN and treatment with FASN inhibitor inactivated the mTOR pathway (Figure 6H; Supplementary Figure 2I; Supplementary Figure 3D, 3F), supporting a tumor suppressor role of FABP5 via inhibition of mTOR through FASN.